Hospira | Evaluate

February 21, 2017

Momenta delay means race for Copaxone generic is on

November 16, 2016

Generic pricing pressure could fuel the urge to merge

September 13, 2016

Teva’s transformation reveals a generics market in turmoil

August 16, 2016

Slimmed-down big pharma starts growing again

July 12, 2016

Who splashed the cash at the top of the market?

April 06, 2016

US biosimilar space reaches its Inflectra point

February 15, 2016

Johnson & Johnson next to suffer from the rise of biosimilars

January 27, 2016

Novartis tries to calm restless investors

January 25, 2016

Time for speciality players to take their Medicines

January 14, 2016

Pfallergan rewrites the takeover record books

November 24, 2015

Pfizer: The once and future M&A king

Load More